Effect of opening a new catheterization laboratory on 30-day and 2-year survival rates in myocardial infarction patients;Impacto de la apertura de un nuevo laboratorio de hemodinámica sobre la supervivencia a 30 días y a 2 años en los pacientes con infarto de miocardio

Revista Espanola de Cardiologia

Volumn 64, Issue 2, 2011, Pages 96-104

  Bosch, Daniel ^a   Masia, Rafel ^a   Sala, Joan ^a   Vila, Joan ^b   Ramos, Rafel ^c   Elosua, Roberto ^b,d   Subirana, Isaac ^b,d   Heras, Magda ^e   Sanchis, Juan ^f   Grau, María ^b   Brugada, Ramon ^a,g   Marrugat, Jaume ^b  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c IDIAP Jordi Gol ^*  (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^g UNIVERSITY OF GIRONA   (Spain)

Author keywords

Catheterization; Coronary artery disease; Health resources and outcomes; Myocardial infarction

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CATHETERIZATION LABORATORY; CONTROLLED STUDY; HAZARD RATIO; HEALTH CARE FACILITY; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; LABORATORY; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREVENTIVE HEALTH SERVICE; SURVIVAL RATE;

ACUTE CORONARY SYNDROME; ADULT; AGE FACTORS; AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; ELECTROCARDIOGRAPHY; ENDPOINT DETERMINATION; FEMALE; FOLLOW-UP STUDIES; HEART CATHETERIZATION; HUMANS; LABORATORIES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RECURRENCE; RISK FACTORS; SEX FACTORS; SURVIVAL RATE;

EID: 79951727061     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2010.07.008     Document Type: Article

References (29)

1. J. Marrugat, R. Elosua, and H. Martí Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997 y 2005 Rev Esp Cardiol. 55 2002 337 346
2. M. Gil, H. Martí, R. Elosua, M. Grau, J. Sala, and R. Masia Análisis de la tendencia en la letalidad, incidencia y mortalidad por infarto de miocardio en Girona entre 1990 y 1999 Rev Esp Cardiol. 60 2007 349 356
3. J. Marrugat, R. Elosua, E. Aldasoro, M.J. Tormo, H. Vanaclocha, and A. Segura Regional variability in population acute myocardial infarction cumulative incidence and mortality rates in Spain 1997 and 1998 Eur J Epidemiol. 19 2004 831 839
4. S.R. Mehta, C.P. Cannon, K.A. Fox, L. Wallentin, W.E. Boden, and R. Spacek Routine vs. selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials JAMA. 293 2005 2908 2917
5. J. Marrugat, G. Sanz, R. Masiá, V. Valle, L. Molina, and M. Cardona Six-month outcome in patients with myocardial infarction initially admitted to tertiary and nontertiary hospitals. RESCATE Investigators. Recursos Empleados en el Síndrome Coronario Agudo y Tiempos de Espera J Am Coll Cardiol. 30 1997 1187 1192
6. J. Marrugat, J. Ferrires, R. Masi, J. Ruidavets, and J. Sala Differences in use of coronary angiography and outcome of myocardial infarction in Toulouse (France) and Gerona (Spain). The MONICA-Toulouse and REGICOR investigators Eur Heart J. 21 2000 740 746
7. F. Van de Werf, J.M. Gore, A. Avezum, D.C. Gulba, S.G. Goodman, and A. Budaj Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study BMJ. 330 2005 441
8. H. Bueno, A. Bardají, A. Fernández-Ortiz, J. Marrugat, H. Martí, and M. Heras Manejo del síndrome coronario agudo sin elevación del segmento ST en España. Estudio DESCARTES (Descripción del Estado de los Síndromes Coronarios Agudos en un Registro Temporal Español) Rev Esp Cardiol. 58 2005 244 252
9. C. Baigent, R. Collins, P. Appleby, S. Parish, P. Sleight, and R. Peto ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. The ISIS-2 (Second International Study of Infarct Survival) Collaborative Group BMJ. 316 1998 1337 1343
10. M.S. Sabatine, C.P. Cannon, C.M. Gibson, J.L. López-Sendón, G. Montalescot, and P. Theroux Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation N Engl J Med. 352 2005 1179 1789
11. The GISSI Collaborative Group Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group Lancet. 2 1986 57 66
12. M.A. Pfeffer, E. Braunwald, L.A. Moyé, L. Basta, E.J. Brown Jr., and T.E. Cuddy Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med. 327 1992 669 677
13. The Scandinavian Simvastatin Survival Study group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet. 344 1994 1383 1389
14. J. Sala, J. Marrugat, R. Masiá, and M. Porta Improvement in survival after myocardial infarction between 1978-85 and 1986-88 in the REGICOR study. (Registre GIroní del COR) registry Eur Heart J. 16 1995 779 784
15. Acute myocardial infarction: pre-hospital and in-hospital management. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J. 1996; 17:43-63.
16. M.E. Bertrand, M.L. Simoons, K.A. Fox, L.C. Wallentin, C.W. Hamm, and E. McFadden Management of acute coronary syndromes: acute coronary syndromes without persistent ST segment elevation; recommendations of the Task Force of the European Society of Cardiology Eur Heart J. 21 2000 1406 1432
17. N.R. Every, E.B. Larson, P.E. Litwin, C. Maynard, S.D. Fihn, and M.S. Eisenberg The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocarial infarction. Myocardial Infarction Triage and Intervention Project Investigators N Engl J Med. 329 1993 546 551
18. D.A. Alter, C.D. Naylor, P.C. Austin, and J.V. Tu Long-term MI outcome at hospitals with or without on-site revascularitation JAMA. 285 2001 2101 2108
19. H.M. Krumholz, J. Chen, J.E. Murillo, D.J. Cohen, and M.J. Radford Admission to hospitals with on-site cardiac catheterization facilities: Impact on long-term cost amb outcomes Circulation. 98 1998 2010 2016
20. H. Van Brabandt, C. Camberlin, F. Vrijens, Y. Parmentier, D. Ramaekers, and L. Bonneux More is not better in the early care of acute myocardial infarction: a prospective cohort analysis on administrative databases Eur Heart J. 27 2006 2649 2654
21. J. Labarere, L. Belle, M. Fourny, N. Gens, J.M. Lablanche, and D. Blanchard Outcome of myocardial infarction in hospitals with percutaneous coronary intervention facilites Arch Intern Med. 167 2007 913 920
22. Y. Fu, W.C. Chang, D. Mark, R.M. Califf, B. Mackenzie, and C.B. Granger Canadian-American differences in the management of acute coronary syndromes in the GUSTO IIb trial: one-year follow-up of patients without ST-segment elevation Circulation. 102 2000 1375 1381
23. I. Ferreira-González, G. Permanyer-Miralda, J. Marrugat, M. Heras, J. Cuñat, and E. Civeira Estudio MASCARA (Manejo del Síndrome Coronario Agudo, Registro Actualizado). Resultados globales Rev Esp Cardiol. 61 2008 803 816
24. F. Arós, A. Loma-Osorio, J. Vila, L. López-Bescós, J. Cuñat, and E. Rodríguez Efecto de la asociación de bloqueadores beta e inhibidores de la enzima de conversión en la supervivencia al año tras sufrir un infarto agudo de miocardio. Resultados del registro PRIAMHO II Rev Esp Cardiol. 59 2006 313 320
25. G.H. Gislason, J.N. Rasmussen, S.Z. Abildstrom, N. Gadsboll, P. Buch, and J. Friberg Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction Eur Heart J. 27 2006 1153 1158
26. M. Heras, J. Marrugat, F. Arós, X. Bosch, J. Enero, and M.A. Suárez Reducción de la mortalidad por infarto agudo de miocardio en un periodo de 5 años Rev Esp Cardiol. 59 2006 200 208
27. A.V. Chobanian, G.L. Bakris, H.R. Black, W.C. Cushman, L.A. Green, and J.L. Izzo Seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure Hypertension. 42 2003 1206 1252
28. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997; 20:1183-97.
29. D. Wood, G. De Backer, O. Faergeman, I. Graham, G. Mancia, and K. Pyörälä Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention Eur Heart J. 19 1998 1434 1503